At JRG Partners, this is the kind of search we run every day, so this piece reflects practice rather than theory. Medical device leadership is being reshaped by several forces at once: software and data becoming central to products, tightening regulatory expectations, reimbursement pressure, and supply chain lessons that have not been unlearned. The leadership profile a device company needs in 2026 is broader than it was a few years ago, and employers hiring to yesterday’s spec are competing for the wrong people.
Key Takeaways
- Software and data capability is now central to device leadership.
- Regulatory expectations continue to tighten, raising the quality bar.
- Reimbursement pressure makes market access capability more valuable.
- Supply chain resilience has become a durable leadership requirement.
- The required leadership profile is broader than it was a few years ago.
Software and Data Move to the Center
Devices increasingly include software, connectivity, and data components, and in many segments the software is where the differentiation lives. This changes what device leadership requires: executives now need enough fluency in software development, cybersecurity, data handling, and the regulatory treatment of software as a medical device to lead credibly. A device leader whose experience is entirely in hardware and mechanical engineering may struggle to govern a product line where software drives both value and risk. Employers should assess software and data fluency as a core requirement rather than a bonus, even for roles that historically did not need it.
Tightening Regulatory and Quality Expectations
Regulatory expectations for device companies have continued to tighten, particularly around post-market surveillance, cybersecurity, real-world evidence, and quality system rigor. This raises the bar for regulatory and quality leadership and pushes those functions further into strategic conversations. Companies that treated quality and regulatory as compliance overhead find that posture increasingly untenable. In practice this means the leaders a device company hires into regulatory and quality roles need more strategic capability than the roles historically required, and other executives need enough regulatory literacy to work with them effectively.
Reimbursement and Market Access Pressure
Payor scrutiny and reimbursement pressure have made market access capability substantially more valuable in device leadership. Getting a device cleared or approved is no longer the finish line; establishing coverage, demonstrating economic and clinical value to payors and health systems, and navigating institutional purchasing have become decisive. Commercial leaders who understand reimbursement deeply, and executives across the leadership team who appreciate its centrality, are increasingly the difference between a cleared product and a commercially successful one. Employers should weight this capability more heavily than they did a few years ago.
Supply Chain as a Standing Requirement
The supply chain disruptions of recent years left a durable mark on device leadership expectations. Operations and supply chain leaders are now expected to build resilience, dual sourcing, supplier qualification depth, visibility, and inventory strategy, rather than optimizing purely for cost. Because supplier changes in devices carry quality and regulatory consequences, this resilience work is more constrained than in other industries and requires leaders who understand both operations and the regulatory implications of supply decisions. Supply chain capability has moved from a functional concern to a leadership-level requirement.
What This Looks Like in Practice
A device company hiring in this environment assesses software and data fluency even for traditionally hardware-oriented roles, expects strategic rather than administrative regulatory and quality leadership, weights reimbursement and market access capability heavily in commercial hires, and treats supply chain resilience as a leadership-level requirement. It hires to the role as it now is. It does not recruit to a specification written for the device industry of several years ago.
The Mistake Employers Keep Making
The most common mistake is hiring to an outdated role specification, a hardware-centric engineering leader for a product line that is becoming software-driven, or a commercial leader assessed mainly on sales results without reimbursement depth. The specification looks reasonable because it describes the role as it once was, and the gap only appears once the leader is in seat and the actual demands of the job diverge from what was assessed.
How Device Leadership Requirements Have Broadened
| Area | Then | Now |
|---|---|---|
| Engineering | Hardware-centric | Software, data, and cybersecurity fluency |
| Regulatory and quality | Compliance function | Strategic capability |
| Commercial | Sales execution | Reimbursement and market access depth |
| Supply chain | Cost optimization | Resilience within regulatory constraints |
The Bottom Line
Device leadership requirements have broadened, software and data fluency, strategic regulatory and quality capability, reimbursement depth, and supply chain resilience, so hire to the role as it now is rather than to a specification written for the industry of several years ago, or you will compete hard for the wrong profile. Hire for the specific demands of the situation, and the rest of the leadership equation gets easier.
Related Reading
For more, see Recruiting for Emerging MedTech Hubs Outside Silicon Valley, How to Recruit Top Talent in a Competitive MedTech Market, Hiring a Chief Commercial Officer for a Medical Device Company.
Frequently Asked Questions
- Q: What is changing most in device leadership?
- A: Software and data have moved to the center of many products, so device executives now need genuine software, cybersecurity, and data fluency alongside traditional capabilities.
- Q: Why does reimbursement matter more now?
- A: Because payor scrutiny has made coverage and demonstrated economic and clinical value decisive, so clearance or approval is no longer the finish line for commercial success.
- Q: How have regulatory expectations shifted?
- A: They have tightened around post-market surveillance, cybersecurity, real-world evidence, and quality rigor, pushing regulatory and quality leadership into strategic rather than compliance roles.
- Q: Is supply chain still a leadership priority?
- A: Yes; resilience expectations have persisted, and because supplier changes carry quality and regulatory consequences, supply chain has become a leadership-level requirement.
- Q: What is the risk of hiring to an old spec?
- A: You compete for a profile that no longer matches the job, and the gap appears once the leader is in seat and the real demands diverge from what was assessed.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
